Tirzepatide access
MedVi vs JoinFridays: Which One Offers Tirzepatide? (2026)
MedVi costs $3,468 a year against $2,856 for JoinFridays. Full 2026 comparison of price, medication class and included support.
Published · Pricing as published in our provider dataset, synced · Editorial scores 9.2 and 9.0 out of 10
We may receive compensation when you click partner links. Rankings are based on research methodology, not sponsorship.
JoinFridays and MedVi both promise a fast route to GLP-1 treatment without an office visit. What they promise afterward is where they separate.
Only one of these two gives you a route to tirzepatide. JoinFridays offers it at $249/mo; MedVi publishes a semaglutide program only, which caps where treatment can go if semaglutide underdelivers.
The sections that follow price both programs across a full course of treatment rather than a first month, then set out which patient each one is actually built for. Gaps in a provider's disclosure are reported as gaps, because they are part of what you are buying.
The short answer
- Lowest 12-month cost
- JoinFridays — $1,800 against $2,592 at MedVi, on each provider's own best published pricing.
- Most support for the money
- JoinFridays — Personalized, clinician-guided care rather than a templated protocol.
- Tirzepatide access
- JoinFridays — Tirzepatide at $249/mo; the other side publishes semaglutide only.
- Widest medication choice
- JoinFridays — compounded semaglutide and compounded tirzepatide.
MedVi vs JoinFridays at a glance
The table is built from each provider's published pricing and program detail; anything they decline to state is marked as such.
| MedVi | JoinFridays | |
|---|---|---|
| Advertised price | $179 promotional first month | From $117/mo |
| Rate after promotions | $299/mo | $249/mo |
| Pricing structure | Promotional first month, then standard rate | Cheaper per month the longer you commit |
| Medication | Compounded semaglutide | Compounded semaglutide and compounded tirzepatide |
| Tirzepatide | Not published | $249/mo |
| State coverage | Not published | Not published |
| Membership fee | None | None |
| How fast you start | Simple online process, no clinic visits | Online intake |
| Shipping | Fast, free shipping | Home delivery |
| Patient reviews | 12,896 | 6,985 |
| eRxDoctor score | 9.2/10 | 9.0/10 |
MedVi vs JoinFridays on total cost, not entry price
GLP-1 treatment is not a one-month purchase, and neither of these prices it like one. These are the totals — six months and twelve — using each provider's own published rates and best available plan.
| MedVi | JoinFridays | |
|---|---|---|
| First month | $179 | $117 |
| Months 2 onward | $299/mo | $249/mo |
| 6-month total | $1,674 | $1,362 |
| 12-month total | $3,468 | $2,856 |
| Best published plan | 3-month plan at $649 — $2,592/yr | 12-month plan at $1,800 — $1,800/yr |
Over a year that is a $792 difference, in JoinFridays's favor. Whether it is the right call depends on whether MedVi gives you $66 a month of something you will use.
Price escalation to plan for: MedVi moves from $179 to $299, a 67% increase and JoinFridays moves from $117 to $249, a 113% increase. Set a calendar reminder for the month it changes.
Semaglutide, tirzepatide, and having somewhere to go next
Semaglutide is a GLP-1 receptor agonist. Tirzepatide adds GIP activity, and in head-to-head trial data it has produced larger average weight reductions. That does not make it the right first choice for everyone — it is typically more expensive and the side-effect profile is its own conversation — but it is the usual next step when semaglutide underdelivers.
JoinFridays publishes both, with tirzepatide at $249/mo. MedVi publishes compounded semaglutide, so switching molecules would mean switching provider, repeating an intake and losing whatever pricing you had locked in.
Optionality has a price and it is usually small. Weigh it against the cost of restarting the whole process elsewhere in six months.
MedVi: what you are buying
The pitch is a genuinely low promotional entry point with 24/7 clinical support behind it. MedVi provides compounded semaglutide starting at $179/month with a simple online intake, no clinic visits, and 24/7 certified medical support for weight loss.
You start with simple online process, no clinic visits; medication arrives via fast, free shipping. The price behaves as promotional first month, then standard rate.
On the clinical side, 24/7 support from certified medical professionals, prescribing compounded semaglutide.
MedVi pros
- 24/7 support from certified medical professionals
- Simple online process with no clinic visits required
- Low promotional first month at $179 including fast, free shipping
- Clinically dosed compounded semaglutide
MedVi cons
- No published outcome or weight loss guarantee
- Compounded medication only, no branded Ozempic or Wegovy
- Semaglutide only, no tirzepatide option
Where it gives ground to JoinFridays: the price roughly doubles to $299 once the promotional month ends.
How JoinFridays works
JoinFridays provides compounded GLP-1 weight loss options starting at $117/month, no long-term contracts, personalized clinician guidance, and active promo codes. In this pairing, its distinguishing feature is the term structure rewards commitment, with a 12-month plan that averages $150 a month.
From signup to first shipment: online intake, then home delivery. Billing follows a cheaper per month the longer you commit structure.
What continues after the first shipment: personalized, clinician-guided care rather than a templated protocol. Formulary: compounded semaglutide and compounded tirzepatide.
JoinFridays pros
- Aggressive promo codes: up to $500 off tirzepatide (NEWYOU12) and up to $400 off semaglutide (NYNY12)
- No membership fees, cancel anytime with no long-term contract
- Both compounded tirzepatide and semaglutide available on one platform
- Lowest starting price in its tier at $117/month
JoinFridays cons
- Lowest tier ($117) reflects introductory or shortest-term pricing; monthly plan is $249
- Compounded medication only, no branded Ozempic, Wegovy, or Zepbound
- Promo code discounts are subject to change and may not always be available
Read next to MedVi, the weak point: the $117 headline is the shortest-term rate; the month-to-month plan is $249.
Which one fits which patient
Choose MedVi if:
- delivery works the way you want it to: fast, free shipping
- you want to start on their timeline: simple online process, no clinic visits
- the level of clinical contact suits you: 24/7 support from certified medical professionals
- what it leads on is worth paying for in your case: a genuinely low promotional entry point with 24/7 clinical support behind it
Choose JoinFridays if:
- you are willing to commit for a term in exchange for a lower effective rate (12-month plan at $1,800)
- the twelve-month total is what you are optimizing ($2,856 against $3,468)
- the monthly rate is the constraint — $249/mo against $299/mo
- you want tirzepatide available without changing provider later
What each one gives up
On price. The monthly gap is 20% in JoinFridays's favor. Whether that is a saving or a false economy turns on one thing: the $117 headline is the shortest-term rate; the month-to-month plan is $249.
On commitment. MedVi rewards a longer commitment (3-month plan at $649), which lowers the effective rate but ties up money before you know how you respond to the medication. Neither publishes financing options, so plan for the full amount each month.
On access. MedVi advertises simple online process, no clinic visits and fast, free shipping; JoinFridays advertises online intake and home delivery. Neither publishes its state coverage, so confirm you are eligible before paying for anything.
On predictability. The pricing structures differ (promotional first month, then standard rate versus cheaper per month the longer you commit), and structure, not headline rate, determines the twelve-month bill.
What the trials and the FDA say
It is worth separating the program from the pharmacology. What follows is true of the medication regardless of which of these two writes the prescription.
Cardiovascular benefit has been demonstrated for semaglutide in a specific population: adults with overweight or obesity and existing cardiovascular disease but no diabetes, per NEJM, SELECT.
In SURMOUNT-4, stopping tirzepatide after a lead-in period produced significant weight regain, where staying on it did not, per JAMA, SURMOUNT-4.
Read alongside the pricing above, that is the case for treating the medication decision as clinical and the provider decision as commercial. They are not the same choice.
MedVi vs JoinFridays: common questions
What happens when MedVi's promotional price ends?
The rate moves to $299/mo, a 67% increase on the advertised entry price. Budget from that number rather than the headline, because it is the one you will pay for eleven of your first twelve months.
Is JoinFridays cheaper than MedVi?
Yes, on the ongoing rate. JoinFridays runs $249/mo once promotional pricing ends, against $299/mo at MedVi — a difference of 20%. Compare the first-month offers separately, because both providers discount entry differently from the rate you will actually be paying by month three.
Which costs less over a year, MedVi or JoinFridays?
JoinFridays, at roughly $1,800 for twelve months against $2,592 at MedVi, using each provider's own best published pricing. Those totals cover medication and program fees as published; they exclude anything a provider bills separately, and they assume you stay on the same plan for the full year.
Which has more patient reviews, MedVi or JoinFridays?
MedVi, with 12,896 against 6,985. Ratings across this market cluster tightly, so volume is the more useful signal: it indicates how much operational load the platform has already absorbed, not how good the medication is.
Do MedVi or JoinFridays take insurance?
Both run on a direct-pay basis: you pay the platform and it does not bill your insurer. Neither publishes HSA/FSA acceptance, so budget the full amount as out-of-pocket spending.
The verdict
JoinFridays is the cheaper year by $792, and for a straightforward course of treatment that settles it.
MedVi earns the difference in one situation: when a genuinely low promotional entry point with 24/7 clinical support behind it is something you will genuinely use. If you cannot say that out loud, take the cheaper program.
Whichever way you go, the medication is the same class of drug and the clinical questions belong to a clinician. What you are choosing here is a billing model and a support structure.
Keep comparing
- MedVi vs Sprout HealthHead to head
- MedVi vs Start WillowTirzepatide access
- Shed vs JoinFridaysPublished price vs quote-only
- Hers vs JoinFridaysBrand-name vs compounded
- Elevate Health vs TMatesTirzepatide access
- Mochi Health vs Elevate HealthTirzepatide access
See every provider in context on the weight loss rankings, or browse the full comparison index.
Disclaimers and methodology
Medical content is informational only and does not replace professional diagnosis, treatment, or emergency care.
Some links are affiliate links and may generate commission at no extra cost to you.
Pricing reflects what each provider published as of the sync date above and changes frequently; confirm the current rate, and the rate at your maintenance dose, before you pay. Six- and twelve-month totals are calculated from those published rates and exclude anything a provider bills separately.
eRxDoctor is an independent publisher. It is not a medical provider, is not affiliated with or endorsed by MedVi or JoinFridays, and does not sell treatment. Read our ranking methodology.